COVID-19 or Flu?
Be prepared for the upcoming respiratory season with Simplexa™ Direct kits
• 'LHUHQWLDO GLDJQRVLV RI &29Ζ' DQG ΖQXHQ]D 'LHUHQWLDWH EHWZHHQ YLUDO LQIHFWLRQV FDXVHG E\ )OX $ )OX % 569 DQG 6$56 &R9 ZLWK WKH 6LPSOH[D )OX $ % 569 'LUHFW NLW DQG WKH 6LPSOH[D &29Ζ' 'LUHFW NLW
• &RQGHQFH LQ \RXU UHVXOWV
'LD6RULQ 0ROHFXODU FRQWLQXDOO\ PRQLWRUV WKH PDMRU X DQG &29Ζ' GDWDEDVHV DQG WHVWV QHZO\ HPHUJLQJ LVRODWHV DV ZHOO DV FXUUHQW X YDFFLQH VWUDLQV RQ DQ RQJRLQJ EDVLV
• 6DPSOH WR DQVZHU ZRUNRZ
5HVXOWV LQ D OLWWOH PRUH WKDQ DQ KRXU DOORZ PRUH HɝFLHQW WHVW UHSRUWLQJ DQG SDWLHQW PDQDJHPHQW 1R 51$ H[WUDFWLRQ UHTXLUHG DQG HDFK NLW FRQWDLQV UHDG\ WR XVH DOO LQ RQH UHDFWLRQ PL[
Learn More
www.molecular.diasorin.com +1 (562) 240-6500
C19PA0620a Product availability subject to required regulatory approvals
Simplexa, LIAISON MDX, and the associated logos are all trademarks or registered WUDGHPDUNV RI 'LD6RULQ 0ROHFXODU //& RU LWV DɝOLDWH LQ WKH 8 6 DQG RU RWKHU FRXQWULHV 7KH 6LPSOH[D &29Ζ'
'LUHFW WHVW LV RQO\ DXWKRUL]HG IRU
the duration of the declaration that circumstances exist justifying the authorization of HPHUJHQF\ XVH RI LQ YLWUR GLDJQRVWLF WHVWV IRU GHWHFWLRQ DQG RU GLDJQRVLV RI &29Ζ' XQGHU 6HFWLRQ
E RI WKH $FW 8 6 & i WHUPLQDWHG RU UHYRNHG VRRQHU EEE E
'LUHFW WHVW KDV QRW EHHQ )'$ FOHDUHG RU DSSURYHG 7KH WHVW KDV
EHHQ DXWKRUL]HG E\ )'$ XQGHU DQ (8$ IRU XVH E\ DXWKRUL]HG ODERUDWRULHV 7KH WHVW KDV been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any RWKHU YLUXVHV RU SDWKRJHQV 7KH 6LPSOH[D &29Ζ'
XQOHVV WKH DXWKRUL]DWLRQ LV The quality of treatment starts with diagnosis.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36